Medicines, Poisons and Therapeutic Goods Amendment Regulation 2016 (No 1) (ACT)

The Medicines, Poisons and Therapeutic Goods Amendment Regulation 2016 (No 1) was challenged in the Supreme Court of the Australian Capital Territory by an intervener who argued that the regulation was invalid because it was not made in accordance with the statutory requirements set out in the Medicines, Poisons and Therapeutic Goods Act 2008. The intervener claimed that the regulation was not properly notified to the Legislative Assembly as required by the Legislation Act, and that it was therefore invalid.

The court considered whether the regulation was validly made and whether it complied with the statutory requirements for its creation. The court noted that the regulation was made under the authority of the Medicines, Poisons and Therapeutic Goods Act 2008 and that it was properly notified to the Legislative Assembly as required by the Legislation Act. The court found that the regulation was validly made and that it complied with the statutory requirements for its creation.

The court held that the regulation was valid and that it did not suffer from any defects that would render it invalid. The court found that the regulation was properly notified to the Legislative Assembly and that it was therefore validly made. The court rejected the intervener's arguments and held that the regulation was valid and enforceable.

The court dismissed the intervener's challenge to the validity of the Medicines, Poisons and Therapeutic Goods Amendment Regulation 2016 (No 1). The court found that the regulation was validly made and that it complied with the statutory requirements for its creation. The court held that the regulation was valid and enforceable, and that it did not suffer from any defects that would render it invalid.